| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Lijun Heng, Joel A Beverley, Heinz Steiner, Kuei Y Tsen. Differential developmental trajectories for CB1 cannabinoid receptor expression in limbic/associative and sensorimotor cortical areas. Synapse (New York, N.Y.). vol 65. issue 4. 2011-12-20. PMID:20687106. |
cannabis use during adolescence is associated with an increased risk for schizophrenia and other disorders. |
2011-12-20 |
2023-08-12 |
rat |
| Paola Casadio, Cathy Fernandes, Robin M Murray, Marta Di Fort. Cannabis use in young people: the risk for schizophrenia. Neuroscience and biobehavioral reviews. vol 35. issue 8. 2011-12-01. PMID:21530584. |
cannabis use in young people: the risk for schizophrenia. |
2011-12-01 |
2023-08-12 |
Not clear |
| Paola Casadio, Cathy Fernandes, Robin M Murray, Marta Di Fort. Cannabis use in young people: the risk for schizophrenia. Neuroscience and biobehavioral reviews. vol 35. issue 8. 2011-12-01. PMID:21530584. |
to date, the research on the impact of its use has largely been epidemiological in nature and has consistently found that cannabis use is associated with schizophrenia outcomes later in life, even after controlling for several confounding factors. |
2011-12-01 |
2023-08-12 |
Not clear |
| Manzar Ashtari, Brian Avants, Laura Cyckowski, Kelly L Cervellione, David Roofeh, Philip Cook, James Gee, Serge Sevy, Sanjiv Kumr. Medial temporal structures and memory functions in adolescents with heavy cannabis use. Journal of psychiatric research. vol 45. issue 8. 2011-11-29. PMID:21296361. |
these data have potential significance for understanding the observed relationship between early cannabis exposure during adolescence and subsequent development of adult psychopathology reported in the literature for schizophrenia and related psychotic disorders. |
2011-11-29 |
2023-08-12 |
human |
| Johannes Rentzsch, Elise Buntebart, Ada Stadelmeier, Jürgen Gallinat, Maria C Jockers-Scherüb. Differential effects of chronic cannabis use on preattentional cognitive functioning in abstinent schizophrenic patients and healthy subjects. Schizophrenia research. vol 130. issue 1-3. 2011-11-23. PMID:21624823. |
however, little is known about the impact of cannabis use on outcome in schizophrenia. |
2011-11-23 |
2023-08-12 |
human |
| Zoltán Makkos, Lilla Fejes, Gabriella Inczédy-Farkas, Akos Kassai-Farkas, Gábor Faludi, Judit Lazár. [Clinical characteristics of cannabis-induced schizophrenia spectrum disorder]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology. vol 13. issue 3. 2011-11-23. PMID:21876221. |
marijuana (cannabis) is the most commonly abused drug by adolescents and young adults and also by people with schizophrenia or other psychotic disorders. |
2011-11-23 |
2023-08-12 |
Not clear |
| Zoltán Makkos, Lilla Fejes, Gabriella Inczédy-Farkas, Akos Kassai-Farkas, Gábor Faludi, Judit Lazár. [Clinical characteristics of cannabis-induced schizophrenia spectrum disorder]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology. vol 13. issue 3. 2011-11-23. PMID:21876221. |
an increasing number of studies suggest that regular cannabis users can show psychotic episodes similar to schizophrenic disorders but it still unclear if cannabis induced psychotic disorder is a distinct entity requiring special therapy or regular cannabis use consequently leads to schizophrenia. |
2011-11-23 |
2023-08-12 |
Not clear |
| Morten V Madsen, Linda P Peacock, Thomas Werge, Maibritt B Andersen, Jesper T Andrease. Effects of cannabinoid CB1 receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys. Neuropharmacology. vol 60. issue 2-3. 2011-11-22. PMID:21029743. |
patients with schizophrenia show increased prevalence of cannabis abuse and this has been linked to severity of eps. |
2011-11-22 |
2023-08-12 |
rat |
| Chaturaka Rodrigo, Senaka Rajapaks. Cannabis and schizophrenia spectrum disorders: a review of clinical studies. Indian journal of psychological medicine. vol 31. issue 2. 2011-11-10. PMID:21938097. |
we searched medline with the key words cannabis and schizophrenia. |
2011-11-10 |
2023-08-12 |
Not clear |
| Eva M Marco, María S García-Gutiérrez, Francisco-Javier Bermúdez-Silva, Fabricio A Moreira, Francisco Guimarães, Jorge Manzanares, María-Paz Vivero. Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects. Frontiers in behavioral neuroscience. vol 5. 2011-11-10. PMID:22007164. |
cannabis consumption has been related to the appearance of psychotic symptoms and schizophrenia. |
2011-11-10 |
2023-08-12 |
Not clear |
| James H Maccab. Estimates of how many cannabis users need to be prevented in order to prevent one case of schizophrenia. Evidence-based mental health. vol 13. issue 2. 2011-10-26. PMID:21856620. |
estimates of how many cannabis users need to be prevented in order to prevent one case of schizophrenia. |
2011-10-26 |
2023-08-12 |
Not clear |
| Wulf Rössler, Stefan Vetter, Mario Müller, William Thomas Gallo, Helene Haker, Wolfram Kawohl, Gianpiero Lupi, Vladeta Ajdacic-Gros. Risk factors at the low end of the psychosis continuum: much the same as at the upper end? Psychiatry research. vol 189. issue 1. 2011-10-11. PMID:21439652. |
risk factors typically assigned to schizophrenia and other psychotic disorders - cannabis use, childhood adversity, reading and writing difficulties, attention deficit hyperactivity disorder (adhd), psychiatric disorders and addiction in parents and the extended family - are relevant also at subclinical levels. |
2011-10-11 |
2023-08-12 |
Not clear |
| Serge Sevy, Delbert G Robinson, Suzanne Sunday, Barbara Napolitano, Rachel Miller, Joanne McCormack, John Kan. Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes. Psychiatry research. vol 188. issue 3. 2011-09-27. PMID:21636134. |
olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes. |
2011-09-27 |
2023-08-12 |
Not clear |
| Serge Sevy, Delbert G Robinson, Suzanne Sunday, Barbara Napolitano, Rachel Miller, Joanne McCormack, John Kan. Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes. Psychiatry research. vol 188. issue 3. 2011-09-27. PMID:21636134. |
the purpose of this study is to compare the efficacy of olanzapine and risperidone for the acute treatment of first-episode schizophrenia patients with cannabis use disorders. |
2011-09-27 |
2023-08-12 |
Not clear |
| Anand Gururajan, David Alan Taylor, Daniel Thomas Malon. Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia. Behavioural brain research. vol 222. issue 2. 2011-09-20. PMID:21458498. |
effect of cannabidiol in a mk-801-rodent model of aspects of schizophrenia. |
2011-09-20 |
2023-08-12 |
rat |
| Anand Gururajan, David Alan Taylor, Daniel Thomas Malon. Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia. Behavioural brain research. vol 222. issue 2. 2011-09-20. PMID:21458498. |
in conclusion, cannabidiol showed both propsychotic activity and partial antipsychotic activity in an mk-801-induced model of aspects of schizophrenia. |
2011-09-20 |
2023-08-12 |
rat |
| Céline Goldberger, Alain Dervaux, David Gourion, Marie-Chantal Bourdel, Henri Lôo, Xavier Laqueille, Marie-Odile Kreb. Variable individual sensitivity to cannabis in patients with schizophrenia. The international journal of neuropsychopharmacology. vol 13. issue 9. 2011-09-01. PMID:20529414. |
variable individual sensitivity to cannabis in patients with schizophrenia. |
2011-09-01 |
2023-08-12 |
human |
| Céline Goldberger, Alain Dervaux, David Gourion, Marie-Chantal Bourdel, Henri Lôo, Xavier Laqueille, Marie-Odile Kreb. Variable individual sensitivity to cannabis in patients with schizophrenia. The international journal of neuropsychopharmacology. vol 13. issue 9. 2011-09-01. PMID:20529414. |
the objective of the present study was to assess the role of individual sensitivity to the psychotogenic effect of cannabis in male patients with schizophrenia. |
2011-09-01 |
2023-08-12 |
human |
| Céline Goldberger, Alain Dervaux, David Gourion, Marie-Chantal Bourdel, Henri Lôo, Xavier Laqueille, Marie-Odile Kreb. Variable individual sensitivity to cannabis in patients with schizophrenia. The international journal of neuropsychopharmacology. vol 13. issue 9. 2011-09-01. PMID:20529414. |
sensitivity to psychotogenic effects of cannabis in schizophrenia patients could be related to both genetic vulnerability to schizophrenia and the influence of cannabis on brain maturation and could modulate the influence of cannabis on the onset of schizophrenia. |
2011-09-01 |
2023-08-12 |
human |
| Monica Rais, Neeltje E M van Haren, Wiepke Cahn, Hugo G Schnack, Claude Lepage, Louis Collins, Alan C Evans, Hilleke E Hulshoff Pol, René S Kah. Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 20. issue 12. 2011-08-26. PMID:20863671. |
cannabis use and progressive cortical thickness loss in areas rich in cb1 receptors during the first five years of schizophrenia. |
2011-08-26 |
2023-08-12 |
human |